Search for: All records

Abstract: In 2019, a series of novel pneumonia cases later known as Coronavirus Disease 2019 (COVID-19) were reported in Wuhan, China. Chest computed tomography (CT) has played a key role in the management and prognostication in COVID-19 patients. CT has demonstrated 98%sensitivity in detecting COVID-19, including identifying lung abnormalities that are suggestive of COVID-19, even among asymptomatic individuals. Methods: We conducted a comprehensive literature review of 17 published studies, including focuses on three subgroups, pediatric patients, pregnant women, and patients over 60 years old, to identify key characteristics of chest CT in COVID-19 patients. Results: Our comprehensive review of the 17 studies concluded that the main CT imaging finding is ground glass opacities (GGOs) regardless of patient age. We also identified that crazy paving pattern, reverse halo sign, smooth or irregular septal thickening, and pleural thickening may serve as indicators of disease progression. Lesions on CT scans were dominantly distributed in the peripheral zone with multilobar involvement, specifically concentrated in the lower lobes. In the patients over 60 years old, the proportion of substantial lobe involvement was higher than the controlgroup and crazy paving signs, bronchodilation, and pleural thickening were more commonly present. Conclusion: Based on all 17 studies, CT findings in COVID-19 have shown a predictable pattern of evolution over the disease. These studies have proven that CT may be an effective approach for early screening and detection of COVID-19. 

Laboratory tests seeking to improve detection of COVID-19 have been widely developed by laboratories and commercial companies. This review provides an overview of molecular and antigen tests, presents the sensitivity and specificity for 329 assays that have received US FDA Emergency Use Authorization and evaluates six sample collection methods – nasal, nasopharyngeal, oropharyngeal swabs, saliva, blood and stool. Molecular testing is preferred for diagnosis of COVID-19, but negative results do not always rule out the presence of infection, especially when clinical suspicion is high. Sensitivity and specificity ranged from 88.1 to 100% and 88 to 100%, respectively. Antigen tests may be more easy to use and rapid. However, they have reported a wide range of detection sensitivities from 16.7 to 85%, which may potentially yield many false-negative results.